Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2022-03-11 Share Issue/Capital Cha…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Freeline registered direct offering
Share Issue/Capital Change Classification · 99% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' header and the concluding statement: 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a specific corporate action: Syncona Limited's participation in a registered direct offering of Freeline Therapeutics ADSs. This type of material, which announces a specific transaction or material event via a regulated news wire service, fits best under the general 'Regulatory Filings' category (RNS) as it is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a specific financing document like a prospectus, but rather the public announcement of the event itself through the designated channel. Since 'RNS' is defined as the fallback for miscellaneous regulatory announcements, it is the most appropriate classification.
2022-03-11 English
Autolus Reports Full Year 2021 Financial Results
Earnings Release Classification · 95% confidence The document is an RNS announcement from Syncona Limited, stating that its portfolio company, Autolus Therapeutics Plc, has reported its 'Fourth Quarter and Full Year 2021 Financial Results and Operational Progress' for the period ended December 31, 2021. The text explicitly states that the announcement can be accessed on Autolus' investor website and that the 'full text of the announcement from Autolus is contained below.' The content below the initial notice includes detailed operational updates, clinical pipeline progress, management changes, and a section titled 'Financial Results for the Quarter and Year Ended December 31, 2021' with specific financial line items (expenses, cash, net loss). Since this document is an announcement *by* Syncona *about* Autolus' results, and the full results are included, it functions as a comprehensive report summary. However, the primary classification must consider the wrapper document type. The wrapper document is an RNS filing (RNS Number: 3606E) announcing the results. Since the document contains detailed financial results for a full year (which typically aligns with a 10-K or IR, but this is a summary/announcement), and it is explicitly distributed via RNS, we must check the definitions. It is not a full 10-K. It contains financial results, but it is presented as an RNS announcement. Given the structure—an RNS wrapper containing the full text of an earnings/results release for a full year—it is most accurately classified as an Earnings Release (ER) if it were the primary release, or an Interim/Quarterly Report (IR) if it were a comprehensive period report. Since it covers the 'Full Year 2021 Financial Results' and is distributed via RNS, it functions as the primary disclosure of annual results, which is often captured by ER or IR depending on the jurisdiction/format. Because it explicitly details the full year's financial results and operational progress, it is more comprehensive than a typical quarterly ER. However, the document is framed as an RNS announcement *referencing* the results. Applying the 'MENU VS MEAL' rule: This document is long (29,684 chars) and contains the substance of the results, not just a link. It is a comprehensive disclosure of annual results. In the context of RNS filings, comprehensive annual results disclosures are often categorized as ER (Earnings Release) or IR (Interim Report). Since it covers the full year, it is analogous to an Annual Report disclosure, but since it's not the formal 10-K, and it's presented as a results announcement, ER is the closest fit for a comprehensive period result announcement, even if it covers the full year. Alternatively, because it is an RNS filing that contains substantial financial information, RNS (General Regulatory Filing) is a strong fallback. Given the explicit inclusion of 'Financial Results for the Quarter and Full Year Ended December 31, 2021' and detailed expense breakdowns, it is a primary results disclosure. We select ER as it announces the results, even though it's comprehensive. If it were purely an announcement *of* the release date, it would be RPA. Since the results are embedded, ER is appropriate. Q4 2021
2022-03-10 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons' and details the purchase of ordinary shares by a Non-Executive Director (Robert Hutchinson). This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing. The RNS Number and the reference to the London Stock Exchange confirm it is a regulatory disclosure. This matches Filing Type Code DIRS.
2022-03-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 2321E' and contains the standard formatting for a regulatory notification disseminated via RNS (Regulatory News Service). Specifically, the form title is 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, crossing notification thresholds. This directly corresponds to the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-03-09 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the RNS Number header and explicitly states it is a 'Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons'. This type of filing reports insider share transactions by directors or senior management. This directly corresponds to the definition for Director's Dealing (DIRS). The document is short and contains specific transaction details, confirming it is the primary filing, not an announcement of a filing.
2022-03-07 English
Achilles reports Full Year 2021 Results
Earnings Release Classification · 99% confidence The document is an RNS announcement from Syncona Limited, noting that its portfolio company, Achilles Therapeutics Plc, announced its 'Full Year 2021 Financial Results' on March 1, 2022. The text provided includes the full text of Achilles' announcement, which details financial highlights for the year ended December 31, 2021, including R&D expenses, G&A expenses, and net loss, along with a Consolidated Balance Sheet. Since this is an announcement by a parent company (Syncona) referencing the release of full-year financial results by a portfolio company (Achilles), and the content is substantial (over 20,000 characters, including tables), it represents the core financial reporting content. However, the primary document structure is an RNS announcement wrapper. Given the content is the full financial results narrative and tables, it strongly aligns with a comprehensive financial report. Since the results are for the 'Full Year 2021', it is most closely related to an Annual Report (10-K) or a comprehensive Interim Report (IR). Because this is a detailed financial release covering the full year, but it is presented via an RNS wrapper and is not explicitly labeled as a 10-K, the most appropriate classification for a comprehensive annual financial disclosure outside of the formal 10-K filing is often the general Annual Report (AR) or, if it were quarterly, IR. Since it covers the full year and contains detailed financial statements, it is a comprehensive financial report. However, the definitions provided distinguish between 10-K (Official yearly report) and AR (Standalone audit reports, applied accounting principles). This document is a press release detailing the results, not the formal 10-K filing itself, nor is it explicitly an audit report. Given the context of RNS announcements often containing Earnings Releases (ER) or comprehensive results, and the document being a detailed summary of the full year's performance including a balance sheet, it functions as the primary disclosure of annual results. If the document were shorter and only summarized highlights, ER would fit. Since it is comprehensive and covers the full year, it is closest to the spirit of the Annual Report (10-K) or a detailed Audit Report (AR) if it contained the auditor's opinion, which it does not explicitly show. Since it is a detailed financial disclosure of the full year's results, and not just a brief earnings release, and it is not the formal 10-K, we classify it as the most comprehensive non-10-K financial report available, which is AR, or potentially ER if we treat the full text as the release. Given the depth (Balance Sheet included), it exceeds a typical ER. We will classify this as an Earnings Release (ER) because it is presented as the announcement of the results via RNS, even though the content is extensive, fitting the definition of 'Initial announcement of quarterly/periodical financial results (key highlights only)' loosely, as this is the initial announcement of the *full year* results by the portfolio company, relayed by the parent. Alternatively, since it is a full-year report summary, it is a strong candidate for AR if we interpret 'Audit Report / Information' broadly as comprehensive financial reporting outside of the 10-K. Given the structure (RNS wrapper announcing results), ER is the most common classification for such detailed press releases announcing period-end results. FY 2021
2022-03-01 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.